Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-08-09
3:11 pm
Purchase
13DArcutis Biotherapeutics, Inc.
ARQT
Frazier Life Sciences VIII L.P.8,745,318
14.6%
263,411increase
(+3.11%)
View
2022-02-15
2:18 pm
Sale
13DAlpine Immune Sciences, Inc.
ALPN
Frazier Life Sciences VIII L.P.3,164,108
10.8%
-13,734decrease
(-0.43%)
View
2022-01-28
1:39 pm
Purchase
13GSierra Oncology Inc.
SRRA
Frazier Life Sciences VIII L.P.1,264,861
8.4%
1,062,058increase
(+523.69%)
View
2021-09-21
3:37 pm
Purchase
13DAlpine Immune Sciences, Inc.
ALPN
Frazier Life Sciences VIII L.P.3,177,842
10%
440,741increase
(+16.10%)
View
2021-05-12
5:27 pm
Sale
13DArcutis Biotherapeutics, Inc.
ARQT
Frazier Life Sciences VIII L.P.8,481,907
16.9%
-2,084,883decrease
(-19.73%)
View
2021-05-04
12:31 pm
Purchase
13DAptinyx Inc.
APTX
Frazier Life Sciences VIII L.P.3,195,055
4.8%
4,976increase
(+0.16%)
View
2021-02-09
11:14 am
Purchase
13DArcutis Biotherapeutics, Inc.
ARQT
Frazier Life Sciences VIII L.P.10,566,790
21.7%
24,000increase
(+0.23%)
View
2021-02-04
4:37 pm
Sale
13DAptinyx Inc.
APTX
Frazier Life Sciences VIII L.P.3,190,079
5.1%
-50,037decrease
(-1.54%)
View
2020-10-06
2:42 pm
Unchanged
13DArcutis Biotherapeutics, Inc.
ARQT
Frazier Life Sciences VIII L.P.10,542,790
24.1%
0
(Unchanged)
View
2020-07-30
8:16 pm
Purchase
13DAlpine Immune Sciences, Inc.
ALPN
Frazier Life Sciences VIII L.P.2,737,101
11.5%
11,475increase
(+0.42%)
View
2020-06-18
12:30 pm
Sale
13DENTASIS THERAPEUTICS HOLDINGS INC.
ETTX
Frazier Life Sciences VIII L.P.799,953
2.9%
-250,000decrease
(-23.81%)
View
2020-04-29
4:46 pm
Sale
13DSierra Oncology Inc.
SRRA
Frazier Life Sciences VIII L.P.202,803
2%
-7,909,318decrease
(-97.50%)
View
2020-03-23
4:07 pm
Sale
13DENTASIS THERAPEUTICS HOLDINGS INC.
ETTX
Frazier Life Sciences VIII L.P.1,049,953
7.9%
-250,000decrease
(-19.23%)
View
2020-02-07
4:04 pm
Purchase
13DArcutis Biotherapeutics, Inc.
ARQT
Frazier Life Sciences VIII L.P.10,542,790
27.7%
10,542,790increase
(New Position)
View
2020-01-16
1:19 pm
Purchase
13DAptinyx Inc.
APTX
Frazier Life Sciences VIII L.P.3,240,116
7.1%
50,037increase
(+1.57%)
View
2020-01-13
10:35 am
Sale
13DENTASIS THERAPEUTICS HOLDINGS INC.
ETTX
Frazier Life Sciences VIII L.P.1,299,953
9.8%
-50,000decrease
(-3.70%)
View
2019-01-22
6:10 pm
Purchase
13DAlpine Immune Sciences, Inc.
ALPN
Frazier Life Sciences VIII L.P.2,725,626
14.6%
526,615increase
(+23.95%)
View
2018-11-13
5:35 pm
Purchase
13DSierra Oncology Inc.
DNAI
Frazier Life Sciences VIII L.P.8,112,121
10.9%
8,112,121increase
(New Position)
View
2018-10-09
06:10 am
Purchase
13DENTASIS THERAPEUTICS HOLDINGS INC.
ETTX
Frazier Life Sciences VIII L.P.1,349,953
10.3%
1,349,953increase
(New Position)
View
2018-07-03
5:42 pm
Purchase
13DAptinyx Inc.
APTX
Frazier Life Sciences VIII L.P.3,190,079
9.5%
3,190,079increase
(New Position)
View